Jean-Marie Hanssens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jean-Marie Hanssens has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Bernard Bourdoncle
1 shared publicationCamille Od Langevin
School of Optometry, Université de Montréal, Montréal, Québec, Canada *
1 shared publicationCarolina Od Quintana-Giraldo
School of Optometry, Université de Montréal, Montréal, Québec, Canada *
1 shared publicationJacques Gresset
Emeritus professor b -Essilor International R&D Vision Science Director 57 rue de Condé 94106 Saint-Maur Cedex France
1 shared publication- Jean-François Bouchard
Université de Montréal, École d’Optométrie, Montreal, Quebec, Canada
1 shared publication - Jocelyn Faubert
Faubert Lab, School of Optometry, University of Montreal, Montreal, QC H3T 1P1, Canada
1 shared publication
Latest Publications
- Open Access
- 10 May 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (10) , 4067
The Montreal Experience: Impact of Different Orthokeratology Lens Designs on Corneal Treatment Zone Characteristics
OBJECTIVE: To evaluate the effect of the orthokeratology (OK) lens design, used in the Montreal Experience cohort, on corneal treatment zone characteristics and their relationship to the pupil. METHODS: This retrospective study follows previously published work and refers to the analysis of 4 different OK lenses. Tangential topography maps were obtained at baseline and after 1 month of OK lens wear. The extracted parameters are: distance treatment zone diameter (DTZD (mm)); relative peripheral power (RPP (D)); mid-peripheral width (MPW (mm)); a new concept, the plus power ratio (PPR (%)), corresponding to the coverage of the pupil area by the positive power zones. RESULTS: DTZD and MPW were significantly different between the lens designs (Welch’s ANOVA). (DTZD (OK 1: 3.68 ± 0.46 mm; OK 2: 3.06 ± 0.67; OK 3: 2.83 ± 0.54; OK 4: 3.20 ± 0.53) MPW (OK 1: 1.65 ± 0.21 mm; OK 2: 1.31 ± 0.40 mm; OK 3: 1.46 ± 0.17 mm; OK 4: 1.57 ± 0.17 mm)). PPR was significantly lower in OK 1 (40.1 ± 22.1%) than the other designs (OK 2: 53.8 ± 18.4%; OK 3: 60.3 ± 13.6; OK 4: 54.7 ± 15.3). CONCLUSION: This study shows that the corneal response to OK lens wear varies with lens design. When analyzed, topographic analysis shows that OK 1 is associated with a larger DTZD, which produces a lower PPR. This may explain why previously published results showed significantly faster axial length (AL) progression with this lens.
- 10 May 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (10) , 4067
Open AccessThe Montreal Experience: Impact of Different Orthokeratology Lens Designs on Corneal Treatment Zone Characteristics
OBJECTIVE: To evaluate the effect of the orthokeratology (OK) lens design, used in the Montreal Experience cohort, on corneal treatment zone characteristics and their relationship to the pupil. METHODS: This retrospective study follows previously published work and refers to the analysis of 4 different OK lenses. Tangential topography maps were obtained at baseline and after 1 month of OK lens wear. The extracted parameters are: distance treatment zone diameter (DTZD (mm)); relative peripheral power (RPP (D)); mid-peripheral width (MPW (mm)); a new concept, the plus power ratio (PPR (%)), corresponding to the coverage of the pupil area by the positive power zones. RESULTS: DTZD and MPW were significantly different between the lens designs (Welch’s ANOVA). (DTZD (OK 1: 3.68 ± 0.46 mm; OK 2: 3.06 ± 0.67; OK 3: 2.83 ± 0.54; OK 4: 3.20 ± 0.53) MPW (OK 1: 1.65 ± 0.21 mm; OK 2: 1.31 ± 0.40 mm; OK 3: 1.46 ± 0.17 mm; OK 4: 1.57 ± 0.17 mm)). PPR was significantly lower in OK 1 (40.1 ± 22.1%) than the other designs (OK 2: 53.8 ± 18.4%; OK 3: 60.3 ± 13.6; OK 4: 54.7 ± 15.3). CONCLUSION: This study shows that the corneal response to OK lens wear varies with lens design. When analyzed, topographic analysis shows that OK 1 is associated with a larger DTZD, which produces a lower PPR. This may explain why previously published results showed significantly faster axial length (AL) progression with this lens.
- Open Access
- 25 August 2023
- Published by Canadian Association of Optometrists in Canadian Journal of Optometry
- Vol. 85 (3) , 11-12
Lettre à la rédaction
- 25 August 2023
- Published by Canadian Association of Optometrists in Canadian Journal of Optometry
- Vol. 85 (3) , 11-12
Open AccessLettre à la rédaction
- Open Access
Distortion in ophthalmic optics: A review of the principal concepts and models
Although all members of the ophthalmic community agree that distortion is an aberration affecting the geometry of an image produced by the periphery of an ophthalmic lens, there are several approaches for analyzing and quantifying this aberration. Various concepts have been introduced: ordinary distortion, stationary distortion and central static distortion are associated with a fixed eye behind the ophthalmic lens, whereas rotatory distortion, peripheral distortion, lateral static distortion, and dynamic distortion require a secondary position of gaze behind the lens. Furthermore, concept definitions vary from one author to another. The goal of this paper is to review the various concepts, analyze their effects on lens design and determine their ability to predict the deformation of an image as perceived by the lens wearer. These entities can be classified within 3 categories: the concepts associated with an ocular rotation, the concepts resulting from an optical approach, and the concepts using a perceptual approach. Among the various concepts reviewed, it appears that the Le Grand-Fry approach for analyzing and displaying distortion is preferable to others and allows modeling of the different possible types of distortions affecting the periphery of an ophthalmic lens.
Open AccessDistortion in ophthalmic optics: A review of the principal concepts and models
Although all members of the ophthalmic community agree that distortion is an aberration affecting the geometry of an image produced by the periphery of an ophthalmic lens, there are several approaches for analyzing and quantifying this aberration. Various concepts have been introduced: ordinary distortion, stationary distortion and central static distortion are associated with a fixed eye behind the ophthalmic lens, whereas rotatory distortion, peripheral distortion, lateral static distortion, and dynamic distortion require a secondary position of gaze behind the lens. Furthermore, concept definitions vary from one author to another. The goal of this paper is to review the various concepts, analyze their effects on lens design and determine their ability to predict the deformation of an image as perceived by the lens wearer. These entities can be classified within 3 categories: the concepts associated with an ocular rotation, the concepts resulting from an optical approach, and the concepts using a perceptual approach. Among the various concepts reviewed, it appears that the Le Grand-Fry approach for analyzing and displaying distortion is preferable to others and allows modeling of the different possible types of distortions affecting the periphery of an ophthalmic lens.
- 1 October 2018
- Published by Wiley in Optometry and Vision Science
- Vol. 95 (10) , 947-952
Shelf Life and Efficacy of Diagnostic Eye Drops
SIGNIFICANCE: Pharmaceutical companies recommend discarding ophthalmic drugs 28 days after opening. This study shows that diagnostic eye drops have a low risk of contamination over a 7‐month period in a controlled clinical setup. The diagnostic efficiency seems to be preserved over this period. PURPOSE: The aim of this study was to evaluate the preservation period and the efficacy of ophthalmic preparations, such as 0.5% proparacaine hydrochloride, 1% tropicamide, 2.5% phenylephrine hydrochloride, and 1% cyclopentolate hydrochloride ophthalmic solution in a clinical and controlled setting. METHODS: Thirty‐eight primary eye care students were recruited to participate in the study. They used 25 bottles of each diagnostic drop at the Clinique Universitaire de la Vision for a 7‐month period. An analysis of the bacterial contamination was repeated 10 times using both an agar plate and a nutrient broth at 0, 2, 4, 6, and 8 weeks and at 3, 4, 5, 6, and 7 months. The anesthetic, mydriatic, and cycloplegic effects were tested after 7 months of use and compared with nonopened ophthalmic bottles. RESULTS: During the 7‐month period, 4971 drops of proparacaine, 3219 drops of tropicamide and phenylephrine, and 1896 drops of cyclopentolate were administered to the patients. A total of 226 contacts between bottles and biological tissues were reported. After the 10 inoculation sessions on the agar medium at the predetermined times, no bacterial and fungal contamination was noted. No patient reported eye infections for 2 weeks after the drop instillation. Moreover, there was no difference in the efficacy when compared with new drops. CONCLUSIONS: According to the results of the current study, diagnostic eye drops can be used with a low contamination risk beyond the recommendation date of 28 days up to 7 months, with the same efficacy, in a controlled clinical context.
- 1 October 2018
- Published by Wiley in Optometry and Vision Science
- Vol. 95 (10) , 947-952
Shelf Life and Efficacy of Diagnostic Eye Drops
SIGNIFICANCE: Pharmaceutical companies recommend discarding ophthalmic drugs 28 days after opening. This study shows that diagnostic eye drops have a low risk of contamination over a 7‐month period in a controlled clinical setup. The diagnostic efficiency seems to be preserved over this period. PURPOSE: The aim of this study was to evaluate the preservation period and the efficacy of ophthalmic preparations, such as 0.5% proparacaine hydrochloride, 1% tropicamide, 2.5% phenylephrine hydrochloride, and 1% cyclopentolate hydrochloride ophthalmic solution in a clinical and controlled setting. METHODS: Thirty‐eight primary eye care students were recruited to participate in the study. They used 25 bottles of each diagnostic drop at the Clinique Universitaire de la Vision for a 7‐month period. An analysis of the bacterial contamination was repeated 10 times using both an agar plate and a nutrient broth at 0, 2, 4, 6, and 8 weeks and at 3, 4, 5, 6, and 7 months. The anesthetic, mydriatic, and cycloplegic effects were tested after 7 months of use and compared with nonopened ophthalmic bottles. RESULTS: During the 7‐month period, 4971 drops of proparacaine, 3219 drops of tropicamide and phenylephrine, and 1896 drops of cyclopentolate were administered to the patients. A total of 226 contacts between bottles and biological tissues were reported. After the 10 inoculation sessions on the agar medium at the predetermined times, no bacterial and fungal contamination was noted. No patient reported eye infections for 2 weeks after the drop instillation. Moreover, there was no difference in the efficacy when compared with new drops. CONCLUSIONS: According to the results of the current study, diagnostic eye drops can be used with a low contamination risk beyond the recommendation date of 28 days up to 7 months, with the same efficacy, in a controlled clinical context.